|
Egg Hypersensitivity
|
C20.543.480.370.150 |
|
|
Dihydromorphine
|
D04.615.723.795.576.350 |
|
|
Mevalonate Kinase Deficiency
|
C16.320.382.750 |
|
|
Ribonucleoside Diphosphate Reductase
|
D08.811.682.810.567 |
|
|
Ribonucleotide Reductases
|
D08.811.682.810 |
|
|
Nucleotidyltransferases
|
D08.811.913.696.445 |
|
|
Permafrost
|
N06.230.124.531.500 |
|
|
Tundra
|
N06.230.124.531 |
|
|
Immunoglobulin J Recombination Signal Sequence-Binding Protein
|
D12.776.660.486 |
|
|
Hydroxycholecalciferols
|
D04.210.500.247.222.159.478 |
|
|
Cholecalciferol
|
D04.210.500.247.222.159 |
|
|
Myelin and Lymphocyte-Associated Proteolipid Proteins
|
D10.570.780.249 |
|
|
Pharmacogenetics
|
D010597 |
[A branch of genetics which deals with the genetic variability in individual responses to drugs and drug metabolism (BIOTRANSFORMATION).
, A subdiscipline of PHARMACOGENETICS using GENOMICS and PROTEOMICS methodology to study genetic variability of responses to drugs and drug metabolism (BIOTRANSFORMATION).
] |
|
Anonymous Testing
|
N06.850.520.308.980.438.580.174 |
|
|
Dysprosium
|
D01.552.550.399.374 |
|
|
Pharmacognosy
|
D010598 |
[The science of drugs prepared from natural-sources including preparations from PLANTS, animals, and other organisms as well as MINERALS and other substances included in MATERIA MEDICA. The therapeutic usage of plants is PHYTOTHERAPY.
] |
|
Pharmacokinetics
|
D010599 |
[Dynamic and kinetic mechanisms of exogenous chemical DRUG LIBERATION; ABSORPTION; BIOLOGICAL TRANSPORT; TISSUE DISTRIBUTION; BIOTRANSFORMATION; elimination; and DRUG TOXICITY as a function of dosage, and rate of METABOLISM. LADMER, ADME and ADMET are abbreviations for liberation, absorption, distribution, metabolism, elimination, and toxicology.
] |
|
Heterogeneous-Nuclear Ribonucleoprotein Group F-H
|
D034541 |
[A group of closely-related heterogeneous-nuclear ribonucleoproteins that are involved in pre-mRNA splicing.
] |
|
Methomyl
|
D02.241.081.251.525 |
|
|
Stakeholder Participation
|
I01.738.805 |
|
